As follows, here is a list of new cancer drugs that show especial promise. Herceptin or trastuzumab is a monoclonal antibody to the HER2 receptor and a recent innovation in breast cancer treatment. In those who have the mutation specific... (Continue reading)
Sutent – an exciting new cancer treatment Sutent, generic sunitinib, is a new cancer medication that has quickly become accepted as a first line treatment for renal cell carcinoma (RCC) as well as a treatment for gastrointestional stromal tumor (GIST)... (Continue reading)
Iressa or gefitinib targets epidermal growth factor receptor and disrupts its intracellular behavior. This was hoped to have significant anti-cancer effects. Unfortunately, it seems increasingly that the clinical benefit of Iressa is limited. Although it showed some benefit in treating... (Continue reading)
Breast cancer is, like all cancers, something that should be caught as early as possible, and testing has proven to be a very good thing. Although the rate of breast cancer rose throughout the 90s, the amount of death it... (Continue reading)
Herceptin, generic trastuzumab, is a new treatment for breast cancer made by Genentech. It is a humanized antibody to the HER2 receptor, which is over expressed in 20-30% of breast cancer. By binding to that receptor and damaging malignant cells,... (Continue reading)
There has been a lot of debate about how to prevent cancer from coming back in post-menopausal women after initial treatment. We discussed in our comparison of Tamoxifen with aromatase inhibitors the debate in general, and now will analyze Tamoxifen... (Continue reading)
Tamoxifen (what is Tamoxifen?) has been the most popular choice as – to put it technical words we’ll explain – “adjuvant therapy for post-initial treatment, early-stage breast cancer that is estrogen receptor positive.” Basically, it helps prevent breast cancer from... (Continue reading)